USD0.000æéå€ååŒÂ  (ET)
35.48MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
2.960å§å€
3.220é«å€
5.74Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
æå€±é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
0.06%売買å転ç
3.180忥çµå€
2.960å®å€
9.35K売買代é
æå€±é¡æ ªäŸ¡åçç
-6.36PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
--ç·è³ç£å©çç
9.99052é±é«å€
0.35åºæ¥é«æ¯ç%
-1.53KçŽå©ç
9.06Mæ ªåŒæ°
-0.73111æ ªåœããå©çïŒEPSïŒ
--ããŒã¿å€
--èªå·±è³æ¬å©çç
1.98052é±å®å€
8.18%æ¯ãå¹
--ç²å©çç
35.48MæäŸ¡ç·é¡
-1.39ãªã¹ã¯ãªã¿ãŒã³
6.87%ãªã¹ã¯ç
Nasus Pharma Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ææšî
ææš
売ã(4)
äžç«(3)
è²·ã(0)
ç§»åå¹³å
売ã(5)
äžç«(0)
è²·ã(1)
Nasus Pharma Ltdã®äŒæ¥æ
å ±î
Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
äŒæ¥ã³ãŒãNSRX
äŒæ¥åNasus Pharma Ltd
æé«çµå¶è²¬ä»»è
ãCEOãTeleman (Dan)
ãŠã§ããµã€ãhttps://www.nasuspharma.com
æ ªäž»çµ±èšî
ãããã質å
Nasus Pharma LtdïŒNSRXïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îNasus Pharma LtdïŒNSRXïŒã®çŸåšã®æ ªäŸ¡ã¯3.20ã§ãã
Nasus Pharma Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îNasus Pharma Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯NSRXã§ãã
Nasus Pharma Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îNasus Pharma Ltdã®52é±é«å€ã¯9.99ã§ãã
Nasus Pharma Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îNasus Pharma Ltdã®52é±å®å€ã¯1.98ã§ãã
Nasus Pharma Ltdã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îNasus Pharma Ltdã®æäŸ¡ç·é¡ã¯28.99Mã§ãã
Nasus Pharma Ltd (NSRX) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãNasus Pharma LtdïŒNSRXïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯19.67ã§ãã
Nasus Pharma Ltd (NSRX) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îNasus Pharma LtdïŒNSRXïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-0.73ã§ãã